SEC Form D · filed October 12, 2023
Iambic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Fred Manby · San Diego, CAExec · DirectorR. Jacob Vogelstein · San Diego, CADirectorEvan Rachlin · San Diego, CADirectorWilliam Rastetter · San Diego, CADirectorJishnu Bhattacharjee · San Diego, CADirectorTabbert Teng · San Diego, CAExecThomas Miller · San Diego, CAExec · DirectorKurt Von Emster · San Diego, CADirectorKurt Von Emster · San Diego, CADirectorEvan Rachlin · San Diego, CADirectorJishnu Bhattacharjee · San Diego, CADirectorR. Jacob Vogelstein · San Diego, CADirectorWilliam Rastetter · San Diego, CADirectorTabbert Teng · San Diego, CAExecThomas Miller · San Diego, CAExec · DirectorFred Manby · San Diego, CAExec · DirectorChao Zhang · San Diego, CAExecDarcy E. Higgs · Vancouver, British Columbia, CanadaExec · DirectorSandra E. Mackay · Vancouver, British Columbia, CanadaDirectorTodd E. Hilditch · Vancouver, British Columbia, CanadaDirectorJohn E. E. Larson · Vancouver, British Columbia, CanadaExecChristina Blacker · Vancouver, British Columbia, CanadaExec · DirectorJohn R. Howard · Dallas, TXDirectorPat S. Bolin · Dallas, TXDirectorJon Myers · Charlottesville, VADirectorChao Zhang · San Diego, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗